Two oral doses of triazolam, 0.5 mg and 0.25 mg, have been compared with placebo in respect of their effects on ventilation, ventilatory response to carbon dioxide, heart rate, arterial pressure, sedation and performance in a variety of psychological tests in 12 healthy volunteers. The study was double-blind. Although triazolam r^iyvi dose-dependent sedation it did not decrease significantly the ventilatory response to carbon dioxide. Respiratory rate was increased by triazolam. After triazolam 0.5 mg, increases in sedation score and deficits in cognitive function were still apparent 6h after administration. Triazolam 0.25 mg produced no significant impairment of performance in any test after 3h. The sensitivity of a number of psychological tests to triazolam has been discussed.
Triazolam (Halcion) is a benzodiazepine with a plasma half-life of less than 4h (Eberts et al., 1981) and its duration of action is one of the shortest among the hypnotic/anxiolytic drugs on the market at the present time. Short acting drugs of this nature are particularly useful as night sedation or as premedication before anaesthesia, where long-term residual effects complicate the subsequent administration of other drugs, and delay recovery.
Some benzodiazepines depress respiration, for example diazepam (Utting and Pleuvry, 1975) and nitrazepam (Rudolf et al., 1978) while others, such as lorazepam (Dodson et al., 1976) , appear to have no effect on respiration, at least when given by the oral route.
This trial was designed to investigate the respiratory and sedative effects of triazolam in volunteers in whom detailed measurements could be made of respiratory effects, without the constraints of time and concurrent drug therapy seen in hospital inpatients.
In a previous study with temazepam (Pleuvry et al., 1980) significant decreases in oral temperature were found. Since hypothermia would be an added complication to anaesthesia this aspect of the drug's activity was assessed at the same time. Since triazolam's hypnotic activity is well documented (Kales et al., 1977; Dahl et al., 1982) it was decided to use the opportunity presented by this study to compare a number of methods of assessing deficits in psychomotor skills and cognitive function.
SUBJECTS AND METHODS
Twelve healthy volunteers (six male) aged between 23 and 38 yr (mean 27 yr) and weighing between 54 and 80 kg (mean 65.2 kg) were studied. Only one subject smoked cigarettes (10 per day). All the subjects consumed alcohol: most of the volunteers considered themselves to be "social" drinkers, although one admitted to being a regular drinker of moderate amounts of alcohol. Written informed consent was obtained. The subjects were fasted from the night before the study and only fruit juice was allowed on the morning of the trial, at least 2 h before the ingestion of the capsule. Food and beverages were allowed 2.5h after taking the capsule, although the subjects were asked to refrain from stimulants such as coffee. The subjects were asked to refrain from consuming alcohol and smoking cigarettes on the day of the trial and to have taken no medication (with the exception of oral contraceptives in two subjects) for 1 week before the trial.
Each volunteer was required to attend on three occasions, at least 1 week elapsing between treatments. Placebo, triazolam 0.25 mg and triazolam 0.5 mg were administered in identical capsules, supplied by Upjohn Limited, using a double-blind procedure in a random order. Ventilation, and the ventilatory response to carbon doxide, were measured by the method described by Redpath and Pleuvry (1982) . A bell closed-circuit spirometer (Ealing) with the cylinder filled with air was used to measure minute volume, tidal volume and respirat-ory rate. Gases were sampled at the mouth-piece and measured continuously by an infra-red carbon dioxide analyser (Morgan) before being returned to the circuit. The carbon dioxide analyser was connected to a Rikadenki single-channel pen recorder so that a continuous record would be obtained. End-tidal . FtC>2 was obtained from this trace. The ventilatory response to carbon dioxide was assessed using a rebreathing method. The soda-lime cannister was removed from the spirometer circuit and the cylinder filled with 5% carbon dioxide in oxygen. Following a maximal expiration, the subject was connected to the spirometer and, after an initial deep inspiration, was allowed to breathe quietly into the apparatus. Rebreathing took place for not more than 5 min. Minute volume was plotted against end-tidal PZO2 and the best straight line calculated by the method of least squares. The slope of each line and the 20-litre intercept were calculated. These measurements were obtained before administration of the drug, and 0.5, 1, 1.5, 2.5, 3.5, 4.5, and 6h following administration. Arterial pressure was measured using an electronic sphygmomanometer (BE 237R) which, preliminary experiments had shown, recorded diastolic pressure at stage 5. Heart rate and arterial pressure were assessed in the sitting position just before the measurements of ventilation.
Sedation was assessed both subjectively and objectively using a visual analogue 100-mm scale marked "wide awake" at one end and "nearly asleep" at the other. Psychomotor function was assessed using the "Leeds Psychomotor Tester". The tester was designed in the Department of Psychology, University of Leeds and comprises a choice reaction time apparatus (Hindmarch, 1975) and a critical flicker fusion threshold apparatus (Hindmarch, 1979) . The two tests were carried out independently.
In the choice reaction time test the subject is required to scan an array of six small lights which are illuminated on a random basis. As soon as the subject detects the light, he or she is expected to touch the appropriate response button and so extinguish the light. The latency of this response is recorded. The distance that the subject moves his or her hand is constant and, thus, it is possible to measure movement time separately from recognition or thinking time. The mean response time over 25 stimulus presentations was recorded. The critical flicker fusion threshold is an index of sedation. The subjects are required to detect flicker in a set of four light-emitting diodes in foveal fixation at 1 m. A mean of six thresholds was taken, three with a gradually increasing rate of flicker where the point where flickering stopped was recorded and three with a decreasing rate of flicker. The point that flickering started was recorded.
Digit symbol substitution (Wechsler, 1944 ) was used as a test of cognitive function. Symbols are substituted for digits according to a code given at the top of the page. The number of symbols correctly substituted in 90s was counted. The time taken to assimilate information was assessed, using the Zahlen-Verbindung Test (Oswald and Roth, 1978) . Twenty-four numbers were arranged randomly in a circle and they have to be connected in ascending order. The time taken for the correct completion of this task is taken.
The final test used in this study was the "traffic lights test" built by the Department of Medical Physics, Manchester Royal Infirmary. The test comprises two toy men, each facing a single set of traffic lights across a pedestrian crossing. The traffic lights flash green "go" or red "stop" in a random sequence. Each man was illuminated in a random sequence and the subject had to decide whether the illuminated man was facing a "go" or "stop" traffic light. The time for this decision could be varied and a maximum number of eight correct decisions could be made. Preliminary studies showed that most adults found this test fairly easy and the shortest decision time, 1 s was selected, so that scores less than 8 could be recorded routinely.
Before starting the trial all subjects were allowed to practise the psychological tests until a consistent performance was obtained. The tests were then carried out in the same order as their descriptions appear in the text before, and 0.75, 1.25, 2, 3, 4, 5 and 6 h after, the administration of the drug. The procedure for the trial was agreed by the University of Manchester Ethics Committee. Significance was assessed using analysis of variance and Duncan's Test. In the case of non parametric data such as traffic light score, Friedman's two-way analysis of variance was used (Seigel, 1956 ).
RESULTS
Triazolam did not significantly affect the respiratory volume or end-tidal PCO2 of the volunteers breathing air (table I) . Neither the slope nor the displacement of the ventilatory response to carbon dioxide was affected by triazolam when minute volume was plotted against end-tidal PcOz. However, triazolam caused a dose-dependent increase in respiratory frequency which was significant 1 and 1.5 h after administration (table II) . The increase in respiratory frequency was coupled with a decrease in tidal volume. One subject, who was heavily sedated by triazolam 0.5 mg, exhibited no ventilatory response to carbon dioxide over 4-5min rebreathing. The response did not return until 3.5 h after the capsule had been taken.
Heart rate and arterial pressure were unaffected by triazolam, but oral temperature was decreased significantly in a dose-dependent manner 1.5 and 2.5h after the administration of triazolam. However, the maximum decrease produced by triazolam 0.5mg was only -0.47±0.11 °C (2.5-h reading) compared with -0.04 ±0.10 "C for placebo As expected, both the sedation scores and the performance in the psychological tests showed highly significant dose-dependent changes. The subjective and objective sedation scores were significantly increased for 5 and 6 h, respectively, after triazolam 0.5mg and for 2 and 3h, respectively, after triazolam 0.25 mg. The lower levels of significance in the subjective score were attributable to a greater variability in scores (table III) . Sedation, as measured by the flicker fusion threshold, was only significant up to 4 h with triazolam 0.5 mg and 2 h with triazolam 0.25 mg ( fig. 1 ). Psychomotor deficits produced by triazolam and measured using the choice reaction time had a shorter duration than changes in sedation score (table IV) . The lack of significance at 3 h in both the recognition time and total reaction time was a result of the high variability in response to triazolam 0.25 mg. Triazolam did not appear to have any differential effect upon recognition time or total reaction time (which included movement time). The traffic lights test was much less sensitive to psychomotor deficits. A significant decrease in performance (P<0.01) was only found with triazolam 0.5mg 2.5h after administration. The mean decrease in correct responses was -1.5 (range 0 to -3), compared with a mean increase in correct responses of +0.2 (range -1 to +2) in subjects given placebo.
The test most sensitive to the actions of triazolam was digit symbol substitution, a test of cognitive fig. 2 ). Triazolam 0.5 mg produced a deficit in performance for at least 6 h after administration, whilst the 0.25-mg dose produced a deficit for 4 h. Subjects given placebo showed a slight increase in performance over the 6 h. The time to assimilate BRITISH JOURNAL OF ANAESTHESIA information, the Zahlen-Verbindung test, was relatively insensitive to the actions of triazolam. Significant increases in the time required to complete the test only occurred with the higher dose of triazolam at 0.75 and 1.25 h (table V) . 
DISCUSSION
Triazolam altered the pattern of respiration, but did not cause consistent changes in the ventilatory response to carbon dioxide. An increase in respiratory frequency occurred in subjects breathing either air or carbon dioxide in oxygen and, to our knowledge, has not been reported with other benzodiazepines. Drowsiness has been reported to cause a displacement of the ventilatory response to carbon dioxide (Eddy et al., 1970) and this may explain the lack of response to carbon dioxide in the most sedated subject. In general, however, there was no correlation between sedation and changes in response to carbon dioxide. Although none of the volunteers complained spontaneously of feelings of cold or warmth, triazolam caused a dose-dependent decrease in oral temperature. Hypothermia with the benzodiazepines has been reported (Irvine, 1966) although, at least in the case of temazepam, this was associated with subjective feelings of cold (Pleuvry et al., 1980) . The small decrease in oral temperature produced by triazolam would have little clinical importance, but it must be remembered that the volunteers in this study were fit young adults. Greater decreases might be seen in patients whose heat generating capacities had been impaired.
Considerable variation in hypnotic activity was observed with both doses of triazolam. There was no significant correlation between sedation score and body weight (Spearman Rank correlation coefficient = 0.25) and, thus, the use of a standard 0.25-mg or 0.5-mg oral dose could not explain this observation. Lader (1979) has reported similar findings with a number of other benzodiazepines. Nevertheless, certain psychological tests, the objective sedation score and digit symbol substitution, showed less variability than other tests. Furthermore, both these tests showed greater sensitivity in assessing the residual effects of triazolam. Significant changes were still detected 6h after triazolam 0.5 mg.
Performance in psychomotor function tests, the choice reaction time and traffic lights test was impaired less by triazolam. This may indicate that triazolam has less depressant effects on psychomotor function than cognitive function and sedation score. An alternative explanation is that the tests are of low sensitivity, although the choice reaction time test has been regarded as a sensitive laboratory analogue of real-life performance in skills such as car driving (Iinnoila and Manila, 1973) .
Without doubt the traffic lights test was not sensitive enough to detect anything but the grossest changes and it is concluded that the test is of little use for assessing psychomotor function in adults.
Critical flicker fusion threshold was found to be inferior to the analogue sedation score as a test of sedation. This was a result of both variability in response and a shift in the fucker fusion threshold to lower values in placebo-treated subjects. This may be attributable to the tedious nature of the test inducing a "placebo hypnosis". The ZahlenVerbindung test is less repetitive than most of the other tests used and the volunteers found it more interesting to do. To some extent these factors may diminish the slowing effect of sedation seen in many psychological tests, so that performance in the Zahlen-Verbindung test is relatively little affected by hypnotic drugs.
In this study triazolam was not found to cause significant respiratory depression when given by mouth. Since previous studies have shown that temazepam does displace the ventilatory response to carbon dioxide in volunteers (Pleuvry et al., 1980) , triazolam might be preferable to temazepam as a short-acting hypnotic for use in anaesthesia. Whilst triazolam 0.5 mg has been reported to be an effective hypnotic with virtually no "hang-over" effect (Hindmarch and Clyde, 1980) , its duration of action in this study was in excess of 6 h. This suggests that triazolam 0.25 mg might be more suitable if an ultra-short duration of hypnotic activity is required. However, whether the depth of sedation produced by this dose of triazolam is sufficient for preanaesthetic medication requires further study. 
EFECTOS SEDATIVOS Y RESPIRATORIOS DEL TRIAZOLAN EN VOLUNTARIOS

SUMAR1O
Se compararon dos dosis orales de triazolan, 0,5 tag y 0,25mg, con el placebo con respecto a sus cfectos sobrc la ventilation, la respuesta ventilatoria al anhidrido carbonico, el ritmo cardiaco, la presion arterial, la sedacion y el rendimiento en una varicdad de ensayos psicologicos llevados a cabo con 12 voluntaries sanos. Se trataba de un estudio doble-ciego. Aunque el triazolan ocasiono una sedacion en relation con la dosis, no disminuyo de manera significativa la respuesta ventilatoria al anhidrido carbonico. El ritmo respiratorio aumento bajo el efecto del triazolan. Despues de 0,5 mg de triazolan, aumentos an la sedacion y deficits de la funcion cognoscitiva todavia se manifestaban 6 horas despues de la administration. El triazolan en dosis de 0,25mg no produjo ningi'in deterioro de rendimiento en cualquiera de los ensayos despues de 3 horas. Se discutio la sensibilidad al triazolan de un numero de ensayos psicologicos.
